Skip to content
Screener

Vaxcyte, Inc. PCVX Q2 2026 earnings

Reported August 5, 2026 · After market close

EPS-$1.97Beat by $0.09
Revenue estimate$12.5M
EPS estimate-$2.06

Next report

Nov 3, 2026 (in 3 months)
Revenue estimate$12.5M
EPS estimate-$2.12

FAQ

When did Vaxcyte, Inc. report Q2 2026 earnings?
Vaxcyte, Inc. (PCVX) reported Q2 2026 earnings on August 5, 2026 after market close.
What were Vaxcyte, Inc.'s Q2 2026 revenue and EPS?
Vaxcyte, Inc. reported eps of $-1.97 for Q2 2026.
Did Vaxcyte, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-2.06 by $0.09.
How did Vaxcyte, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 61.5% from $-1.22.
Where can I find Vaxcyte, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001649094-26-000041) and the 10-Q periodic report (0001649094-26-000043) directly on SEC EDGAR. The filing index links above go to sec.gov.